Z-338
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Functional Dyspepsia
Conditions
Functional Dyspepsia
Trial Timeline
Apr 1, 2006 → Oct 1, 2009
NCT ID
NCT00323817About Z-338
Z-338 is a phase 2 stage product being developed by Zeria Pharmaceutical for Functional Dyspepsia. The current trial status is completed. This product is registered under clinical trial identifier NCT00323817. Target conditions include Functional Dyspepsia.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01973790 | Phase 3 | Completed |
| NCT00458328 | Phase 2 | Completed |
| NCT00333372 | Phase 2 | Completed |
| NCT00323817 | Phase 2 | Completed |
| NCT00298194 | Phase 2 | Completed |
Competing Products
20 competing products in Functional Dyspepsia